Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Türbachova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Epigenetics|November 14, 2007
DNA methylation analysis as a tool for cell typingUdo Baron, Ivana Türbachova, Alexander Hellwag, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 15, 2016
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) ConsortiumDesislava Dimitrova, Ilary Ruscito, Sven Olek, et al.
European Journal of Immunology|August 19, 2007
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cellsUdo Baron, Stefan Floess, Georg Wieczorek, et al.
Epigenetics|September 28, 2013
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patternsIvana Türbachova, Tim Schwachula, Ines Vasconcelos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Epigenetics|November 14, 2007
DNA methylation analysis as a tool for cell typingUdo Baron, Ivana Türbachova, Alexander Hellwag, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 15, 2016
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) ConsortiumDesislava Dimitrova, Ilary Ruscito, Sven Olek, et al.
European Journal of Immunology|August 19, 2007
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cellsUdo Baron, Stefan Floess, Georg Wieczorek, et al.
Epigenetics|September 28, 2013
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patternsIvana Türbachova, Tim Schwachula, Ines Vasconcelos, et al.
Pageof 1